Allogene Therapeutics (ALLO) Other Operating Expenses (2019 - 2025)
Allogene Therapeutics (ALLO) posted Other Operating Expenses of $2.4 million for Q2 2025, down 77.8% sequentially from $10.7 million in Q3 2024, and down 52.25% YoY from $5.0 million in Q2 2024.
Allogene Therapeutics (ALLO) Other Operating Expenses (2019 - 2025) Analysis & Trends
Allogene Therapeutics has reported Other Operating Expenses for 4 years, with the latest figure at $2.4 million in Q2 2025.
- Quarterly Other Operating Expenses fell 52.25% year-over-year to $2.4 million in Q2 2025, while the trailing twelve-month figure through Mar 2026 was $2.4 million (down 84.84% YoY) and the FY2025 annual result came in at $2.4 million, down 84.84% from the prior year.
- Other Operating Expenses declined to $2.4 million in Q2 2025 per ALLO's latest filing, from $10.7 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $13.2 million in Q4 2023 and troughed at $2.4 million in Q2 2025.
- A 3-year average of $7.8 million and a median of $7.9 million in 2024 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 52.25% in 2025, down 52.25% in 2025.
- Over 3 years, Other Operating Expenses stood at $13.2 million in 2023, then declined by 19.0% to $10.7 million in 2024, then plunged by 77.8% to $2.4 million in 2025.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $2.4 million, $10.7 million, and $5.0 million for Q2 2025, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Allogene Therapeutics | 707.96 Mn | 707.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.38 Mn |
| Sep 30, 2024 | 10.73 Mn |
| Jun 30, 2024 | 4.99 Mn |
| Dec 31, 2023 | 13.25 Mn |
| Dec 31, 2019 | 134.54 Mn |